Related Experiment Video
Updated: Nov 9, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Neurosteroid involvement in threatened preterm labour
Sahruh Turkmen1, Torbjörn Bäckström1, Yvonne Kangas Flodin1
1Sundsvalls Research Unit, Department of Clinical Sciences, Obstetrics and Gynaecology, Umeå University, Sundsvall, Sweden.
This study found that while oxytocin levels were higher in women with threatened preterm labor, neurosteroid levels and GABAA receptor function remained unchanged. These findings suggest neurosteroids may not be directly involved in the risk of preterm labor.
Area of Science:
- Neuroendocrinology
- Obstetrics
- Neuropharmacology
Background:
- The neurosteroid allopregnanolone influences oxytocin expression via the GABAA receptor.
- The role of neurosteroid levels and GABAA receptor function in preterm labor risk is not understood.
Purpose of the Study:
- To investigate whether neurosteroid levels and GABAA receptor function are associated with threatened preterm labor (TPL) in pregnant women.
Main Methods:
- Prospective study of pregnant women with (n=16) or without (n=20) TPL.
- Measured plasma levels of allopregnanolone, progesterone, and oxytocin.
- Assessed GABAA receptor function using saccadic eye velocity test (SEVT).
Main Results:
- Plasma oxytocin levels were significantly higher in the TPL group.
- Allopregnanolone and progesterone levels did not differ between groups, but oxytocin showed a negative association with allopregnanolone in the TPL group.
- GABAA receptor function, as measured by SEVT, was similar in both groups.
Conclusions:
- Peripheral neurosteroid levels were not altered in women with TPL, despite increased oxytocin.
- GABAA receptor function appeared unchanged in women experiencing TPL.
- Further investigation using GABAA receptor agonist challenge tests is recommended to confirm GABAA receptor function reliability.
Related Concept Videos
Teratogenicity
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis

